thymoquinone has been researched along with Degenerative Diseases, Central Nervous System in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 5 (55.56) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Qahtani, WS; AlAsmari, AF; Alasmari, F; Alotaibi, FM; Alqahtani, F | 1 |
| Alam, MS; Alshehri, S; Ghoneim, MM; Gilani, SJ; Imam, SS; Kala, C; Qizilbash, FF; Sartaj, A; Taleuzzaman, M; Verma, R | 1 |
| Akçay, E; Çakir, Z; Gevrek, F; Özsoy, Ş | 1 |
| Chetverikov, NS; Genrikhs, EE; Illarioshkin, SN; Isaev, NK; Khaspekov, LG; Stelmashook, EV | 1 |
| Clinton, CD; Hoq, MI; Ibrahim, M; Islam, MS; Jahan, I; Jakaria, M; Siddiqui, SA; Uddin, MN | 1 |
| Farkhondeh, T; Samarghandian, S; Samini, F | 1 |
| Ardah, MT; Haque, ME; Merghani, MM | 1 |
| Altinoz, MA; Elmaci, I | 1 |
| Asghari, M; Mousavi, SH; Sadeghnia, HR; Tayarani-Najaran, Z | 1 |
6 review(s) available for thymoquinone and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
Therapeutic Effects of Thymoquinone on Alzheimer's Disease through Modulating Amyloid-beta Neurotoxicity and Neuro-inflammatory Cytokine Levels.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cytokines; Neurodegenerative Diseases; Neuroinflammatory Diseases | 2023 |
An Overview of the Neuropharmacological Potential of Thymoquinone and its Targeted Delivery Prospects for CNS Disorder.
Topics: Benzoquinones; Central Nervous System Diseases; Drug Delivery Systems; Humans; Neurodegenerative Diseases; Nigella sativa; Plants, Medicinal | 2022 |
Thymoquinone as a Potential Neuroprotector in Acute and Chronic Forms of Cerebral Pathology.
Topics: Acute Disease; Benzoquinones; Brain; Chronic Disease; Humans; Neurodegenerative Diseases; Neuroprotective Agents | 2020 |
The Mechanistic Role of Thymoquinone in Parkinson's Disease: Focus on Neuroprotection in Pre-Clinical Studies.
Topics: Benzoquinones; Humans; Neurodegenerative Diseases; Neuroprotection; Neuroprotective Agents; Parkinson Disease | 2021 |
A Review on Possible Therapeutic Effect of Nigella sativa and Thymoquinone in Neurodegenerative Diseases.
Topics: Animals; Benzoquinones; Humans; Neurodegenerative Diseases; Nigella sativa; Plant Extracts; Plants, Medicinal | 2018 |
Thymoquinone: An edible redox-active quinone for the pharmacotherapy of neurodegenerative conditions and glial brain tumors. A short review.
Topics: Animals; Antineoplastic Agents; Benzoquinones; Brain Neoplasms; Glioma; Humans; Neurodegenerative Diseases; Oxidation-Reduction | 2016 |
3 other study(ies) available for thymoquinone and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
Effects of thymoquinone and memantine alone and in combination on memory and hippocampal morphology in rats with streptozotocin-induced Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Disease Models, Animal; Hippocampus; Male; Maze Learning; Memantine; Neurodegenerative Diseases; Rats; Streptozocin | 2023 |
Thymoquinone prevents neurodegeneration against MPTP in vivo and modulates α-synuclein aggregation in vitro.
Topics: alpha-Synuclein; Animals; Benzoquinones; Cell Line, Tumor; Corpus Striatum; Humans; Male; Mice; Mice, Inbred C57BL; Neurodegenerative Diseases; Parkinsonian Disorders; Protein Aggregates | 2019 |
Protective effect of Nigella sativa extract and thymoquinone on serum/glucose deprivation-induced PC12 cells death.
Topics: Animals; Benzoquinones; Brain Ischemia; Cattle; Cell Death; Cell Survival; Culture Media, Serum-Free; Glucose; Humans; Neurodegenerative Diseases; Neurons; Nigella sativa; PC12 Cells; Plant Extracts; Rats; Reactive Oxygen Species | 2010 |